Current and Emerging Systemic Therapies for Hepatocellular Carcinoma: Clinical Evidence and Guideline Recommendations

Download this slideset for expert perspectives on best practices with available systemic therapy regimens for patients with advanced hepatocellular carcinoma, including immune checkpoint inhibitor combinations.

Adam Burgoyne, MD, PhD Lipika Goyal, MD Stacey Stein, MD Released: February 4, 2022

Download this slideset for expert perspectives on novel systemic therapy regimens for patients with advanced hepatocellular carcinoma, including PD-1/PD-L1 inhibitor plus CTLA-4 inhibitor or multikinase inhibitor combinations.

Adam Burgoyne, MD, PhD Lipika Goyal, MD Stacey Stein, MD Released: February 4, 2022

Download this slideset for expert perspectives on emerging strategies in using immune checkpoint inhibitor combinations for patients with early- and intermediate-stage hepatocellular carcinoma.

Adam Burgoyne, MD, PhD Lipika Goyal, MD Stacey Stein, MD Released: February 4, 2022

Read this commentary on expert responses to questions asked by healthcare professionals during a webinar series on best practices and emerging strategies in treating patients with hepatocellular carcinoma.

Adam Burgoyne, MD, PhD Lipika Goyal, MD Stacey Stein, MD Released: March 21, 2022